Evaluation of Cytosponge testing for urgent suspected cancer referrals during COVID-19 related suspension of endoscopy services

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-225

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principle Investigator

    Pending
  • Research Location

    United Kingdom, Europe
  • Lead Research Institution

    MRC Cancer Unit
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Other

  • Occupations of Interest

    Unspecified

Abstract

Upper GI endoscopy services are severely limited in view of the risks of aerosol spread of coronavirus. This risks a delay in cancer diagnosis and a back-log of endoscopy referrals to facilitate once services resume. We have fast-tracked the Cytosponge technology developed in Cambridge to provide a triage service for 2WW referrals.